Publications
- Skin rash as useful marker of erlotinib efficacy in NSCLC and its impact on clinical practice2013 | Faculty of Medicine in Pilsen
- Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplification2011 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Adverse skin reaction to erlotinib therapy2010 | Central Library of Charles University
- Adverse skin reaction to erlotinib therapy2010 | Faculty of Medicine in Pilsen
- Erlotinib-induced papulopustular rash spares previously irradiated skin - a case report2010 | Faculty of Medicine in Pilsen
- Hair diseases2023 | Faculty of Medicine in Pilsen
- Akutní stavy ve vnitřním lékařství2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Topical bimatoprost in the treatment of eyelash loss in alopecia totalis and universalis: A prospective, open-label study2022 | Faculty of Medicine in Pilsen
- Clinicopathological features, MCPyV status and outcomes of Merkel cell carcinoma in solid-organ transplant recipients: a retrospective, multicentre cohort study2022 | Faculty of Medicine in Pilsen
- Case studies in dermatology2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Physical Education and Sport
Loading network view...